Division of Pediatric Cardiology, CHU Ste-Justine, University of Montreal, Montreal, QC H3T 1C5, Canada.
Diagnostics (Basel). 2013 Jan 10;3(1):1-12. doi: 10.3390/diagnostics3010001.
Making a diagnosis of Kawasaki disease with certainty may be challenging, especially since the recognition of cases with incomplete diagnostic criteria and its consequences. In order to build the diagnostic case in daily practice, clinicians rely on clinical criteria established over four decades ago, aided by non specific laboratory tests, and above all inspired by experience. We have recently studied the diagnostic value of N-terminal pro B-type natriuretic peptide to improve the diagnostic certainty of cases with complete or incomplete clinical criteria. Our working hypothesis was based on the fact that myocarditis is present in nearly all Kawasaki disease patients supported by histology data. In this paper, we review these facts and the myocardial perspective from the diagnostic and the mechanistic standpoints.
明确诊断川崎病可能具有挑战性,特别是在认识到不完全符合诊断标准的病例及其后果的情况下。为了在日常实践中建立诊断病例,临床医生依赖于四十多年前确立的临床标准,辅以非特异性实验室检查,最重要的是借鉴经验。我们最近研究了 N 末端脑利钠肽原在改善完全或不完全临床标准病例的诊断确定性方面的诊断价值。我们的工作假设基于这样一个事实,即心肌炎症几乎存在于所有川崎病患者中,这一事实得到了组织学数据的支持。在本文中,我们从诊断和发病机制的角度回顾了这些事实和心肌观点。